Powering Patient Care

Would you like to visit the Werfen website for North America?

Yes

No

ABOUT WERFEN

Powering Patient Care

In everything we do, we use our passion and long-term vision to develop meaningful innovations that truly enhance patient care and help create healthier societies worldwide.

Werfen at a glance

Werfen is a growing, family-owned, innovative company founded in 1966 in Barcelona, Spain.

We are a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant.

We operate directly in 30 countries, and in more than 100 territories through distributors. Our headquarters are in Barcelona, Spain and our Technology Centers are located in the United States and Europe. Worldwide sales in 2024 were almost € 2.2 billion and our workforce is 7,000 strong.

Clinical areas of expertise

Hemostasis

Our Hemostasis product portfolio comprises in vitro diagnostic systems, reagents, data management solutions, automation, and service, used to diagnose and guide treatment of thrombotic and bleeding disorders. Ultimately, Werfen's Hemostasis solutions improve the quality of patient care, lower costs, and assure regulatory compliance in the clinical laboratory.

Acute Care Diagnostics

From cardiovascular operating rooms and catheterization labs, to intensive care units and emergency departments, Werfen’s Acute Care Diagnostic solutions are integrated and comprehensive. This whole blood testing portfolio line helps clinicians and laboratorians save time, lower costs, assure regulatory compliance and improve patient outcomes.

Transfusion

Offering the broadest range of manual and automated solutions, our Transfusion portfolio delivers results accurately, efficiently and productively. A comprehensive line of serology reagents, fully automated instrumentation, industry-leading data management software and molecular products, help ensure donor-recipient compatibility for those in need of a lifesaving blood transfusion.

Autoimmunity

Through a dedicated focus on in vitro diagnostics and lab automation for Autoimmunity, our highly accurate reagents and automated systems are designed to serve labs of all sizes. Werfen’s solutions help improve the way patients with Autoimmune diseases are diagnosed, monitored, and treated.

Transplant

Featuring molecular and antibody-based assays and software for specialized HLA testing, our Transplant products are used to determine pretransplant compatibility between donors and recipients, and for post-transplant monitoring. By providing high-quality assays, accurate test results, and innovative tools, we can help change the practice of transplant medicine.

2024 Digital Annual Review

Read about our people, performance, and achievements in 2024.

Click here

Werfen and its affiliates

Non-financial Information Statement

Report 2021Report 2022Report 2023Report 2024Report 2025

Our Code of Ethics

The Werfen Code of Ethics demonstrates our commitment to integrity and the highest ethical standards. It guides our daily business behavior and shows the values we share throughout the organization.

Learn more

Sustainability

We believe in the importance of sustainability for our people, our planet and our profitability.

We are a signatory of the UN Global Compact, and we commit to the UN Sustainable Development Goals:

• Proactively managing our internal operations and supply chain;
• Launching Corporate Social Responsibility programs;
• Diversity and Inclusion practices;
• Through the products, solutions, systems and services we offer our customers.

REPORT 2025PRINCIPLESPOLICIES

Our approach to sustainability

View video

The 3P's of sustainability

We are focused on three areas - equally important and interconnected.

People

Social equality: Our commitment to human rights, security, equality, inclusion and diversity in all respects.

People

Planet

Environmental protection: Our impact on the environment including CO2 emissions, waste management or biodiversity.

Planet

Prosperity

Economic development: Our economic growth and our efficiency using resources like energy or materials.

Prosperity

WHAT'S HAPPENING

News

Something new is always happening in our world, keep up to date with news

•

NEWS

Autoimmunity

October 6, 2026 - San Diego, CA

Werfen Launches QUANTA Link® 5.0: A Modern, Web-Based Platform for Autoimmune Laboratory Workflow Management

...

View News Article

Corporate

September 22, 2026 - SAN DIEGO, California

Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent

...

View News Article

Corporate

August 19, 2026 - Bedford, Massachusets

WERFEN RECEIVES 2026 IMV ServiceTrak™ AWARDS FOR BEST CUSTOMER SATISFACTION, SYSTEM PERFORMANCE AND SERVICE IN COAGULATION

...

View News Article

Corporate

May 14, 2026 - Barcelona, Spain

Werfen and Oxford Nanopore enter strategic collaboration to support development of advanced transplant assays

...

View News Article

VIEW ALL NEWS